Pheneturide
 | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-N-carbamoyl-2-phenyl-butanamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
90-49-3  |
| ATC code | N03AX13 (WHO) |
| PubChem | CID 72060 |
| ChemSpider |
65046  |
| UNII |
878CEJ4HGX |
| KEGG |
D01190 |
| Chemical data | |
| Formula | C11H14N2O2 |
| Molar mass | 206.241 g/mol |
| Chirality | Racemic mixture |
| |
| |
| (what is this?) (verify) | |
Pheneturide (INN, BAN) (brand names Benuride, Deturid, Pheneturid, Septotence, Trinuride),[1] also known as phenylethylacetylurea (or ethylphenacemide), is an anticonvulsant of the ureide class.[2][3] It is considered to be obsolete,[4] and is now seldom used.[5] It is marketed in Europe, including in Poland, Spain, and the United Kingdom.[6] Pheneturide has a similar profile of anticonvulsant activity and toxicity relative to phenacemide,[7] but is less toxic in comparison, despite still being a toxic drug.[8] As such, it is only used in cases of severe epilepsy when other, less-toxic drugs have failed.[8] Pheneturide inhibits the metabolism and thus increases the levels of other anticonvulsants, such as phenytoin.[5][6]
See also
References
- ↑ Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 998–. ISBN 978-3-7692-2114-5.
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 959–. ISBN 978-1-4757-2085-3.
- ↑ Byrne B, Rothchild R (1999). "1H NMR studies of drugs with achiral and chiral lanthanide shift reagents: applications to the anticonvulsant pheneturide". Chirality 11 (7): 529–35. doi:10.1002/(SICI)1520-636X(1999)11:7<529::AID-CHIR3>3.0.CO;2-K. PMID 10423278.
- ↑ René H. Levy (2002). Antiepileptic Drugs. Lippincott Williams & Wilkins. pp. 210–. ISBN 978-0-7817-2321-3.
- 1 2 M.J. Denham (6 December 2012). The Treatment of Medical Problems in the Elderly. Springer Science & Business Media. pp. 335–. ISBN 978-94-011-6223-4.
- 1 2 Julius Vida (19 July 2013). Anticonvulsants. Elsevier. pp. 4,42. ISBN 978-0-323-14395-0.
- ↑ George deStevens; V. Zingel; C. Leschke; W. Schunack, Paul D. Hoeprich, Richard M. Schultz, P.K. Mehrotra, Sanjay Batra, A.P. Bhaduri, Anil K. Saxena, Mridula Saxena (11 November 2013). Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Birkhäuser. pp. 217–. ISBN 978-3-0348-7161-7. Cite uses deprecated parameter
|coauthors=(help) - 1 2 Richard Lancaster (22 October 2013). Pharmacology in Clinical Practice. Elsevier. pp. 222–. ISBN 978-1-4831-9294-9.
| ||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.